Acta Med. 2003, 46: 171-174

https://doi.org/10.14712/18059694.2019.28

Cardiac Troponins Following Repeated Administration of an Iron Chelator – Salicylaldehyd Isonicotinoyl Hydrazone (SIH) – in Rabbits

Michaela Adamcováa, Martin Štěrbab, Ivona Klimtovác, Tomáš Šimůnekc, Radomír Hrdinac, Vladimír Geršlb, Přemysl Poňkad

aCharles University in Prague, Faculty of Medicine in Hradec Králové, Department of Physiology, Hradec Králové, Czech Republic
bCharles University in Prague, Faculty of Medicine in Hradec Králové, Department of Pharmacology, Hradec Králové, Czech Republic
cCharles University in Prague, Faculty of Pharmacy in Hradec Králové, Department of Pharmacology and Toxicology, Hradec Králové, Czech Republic
dMcGill University, Department of Physiology and Medicine, Montréal, Québec, Canada

Received July 1, 2003
Accepted August 1, 2003

References

1. Adamcová M, Geršl V, Hrdina R, Palička V, Mazurová Y. Contribution to prediction and pathogenesis of daunorubicin-induced cardiomyopathy in rabbits. Exp Clin Cardiol 1998; 3(3):179–83.
2. Adamcová M, Geršl V, Hrdina R et al. Cardiac troponin T as a marker of myocardial damage caused by antineoplastic drugs in rabbits. J Cancer Res Clin Oncol 1999; 125 (5):268–74.
3. Adamcová M, Macháčková J, Geršl V et al. Cardiac troponin T following repeated administration of pyridoxal isonicotinoyl hydrazone in rabbits. Phys Res 2002; 51(5):443–8.
4. Adamcová M, Geršl V, Macháčková J et al. Troponins in experimental studies. Acta Med (Hradec Králové) Suppl 2002; 45(1):29–32.
5. Engliš M. Troponin T (cTnT) nebo troponin I (cTnI): je to (ta správná) otázka? Labor Aktuell 1998; 4:12–3.
6. Katrukha A, Bereznikova A, Filatov V et al. Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem 1998; 44:2433–40.
7. Klimtová I, Šimůnek T, Geršl V et al. Biochemical and haematological changes following repeated pyridoxal isonicotinoyl hydrazone administration in rabbits. Biomarkers Environ 2001; 4(Suppl 1):70–5.
8. Laurino JP. Troponin I: an update on clinical utility and metod standartization. An Clin Lab Science 2000; 30(4): 412–21.
9. Morjana NA. Degradation of human cardiac troponin I after myocardial infarction. Biotechnol Appl Biochem 1998; 28:105–11.
10. O’Brien PJ, Dameron GW, Beck ML, Brandt M. Differential reactivity of cardiac and skeletal muscle from various species in two generations of cardiac troponin immunoassays. Res Vet Sci 1998; 65(2):135–7. <https://doi.org/10.1016/S0034-5288(98)90164-3>
11. O’Brien PJ, Dameron GW, Beck ML et al. Cardiac troponin T is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim Science 1997; 47(5):486–95.
12. Šimůnek T, Klimtová I, Hrdina R et al. The effects of repeated administration of pyridoxal isonicotinoyl hydrazone on cardiovascular system in rabbits. Biomarkers Environ 2001; 4 (suppl 1):93–7.
13. Sookvanichsilp N, Nakornchai S, Weerapradist W. Toxicological study of pyridoxal isonicotinoyl hydrazone: acute and subchronic toxicity. Drug Chem Toxicol 1991; 14:395–403. <https://doi.org/10.3109/01480549109011641>
14. Wu AHB. Role of serum biochemical markers in clinical trials. In: Myocardial damage, Kasi JC and Holt DW (eds.) Developments in Cardiovascular Medicine. Kluwer Academic Publishers 1998; 205:189–98.
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)

Open access journal

Archive